Relevant BNF section: 3.1.1
β2-selective adrenoceptor agonists (β2-stimulants) have been used for 30 years for the relief of symptoms in patients with all grades of asthma. They can also be used before activities likely to precipitate airway narrowing and are sometimes taken as regular treatment by patients with chronic asthma. The first β2-stimulants to be introduced were shorter-acting drugs such as salbutamol and terbutaline. The longer-acting β2-stimulants, salmeterol and ▼eformoterol were developed more recently and their role in treating asthma is not yet fully defined. In this article we review the current place of β2-stimulants in asthma management.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.